Skadden Arps Slate Meagher & Flom

Comment: A firm highly recommended for IPOs and secondary offerings that has further refined its profile. One focus is on advice to banks on real estate company transactions. Here the firm often faces Sullivan & Cromwell on the side of the issuers, e.g. in the secondary offering of TLG and the planned IPO of Office First, which in the end led to the sale of the company. But the team is also active in other branches as well: its banking work on the IPO of the mail-order pharmacy Zur Rose demonstrates that the practice enjoys a significant flow of transactions year after year, often with a connection to the US, as was the case here. Clients often come from other European countries.
Strengths: Well-rehearsed team, extensive experience in complex deals. Outstanding bank contacts.
Recommended: Dr. Stephan Hutter (“good for difficult negotiating situations, charismatic”, “extremely large pool of experience”, competitors), Dr. Katja Kaulamo (“has gained in visibility”, competitor).
Practice: IPOs, secondary offerings, complex transactions, also advice on US law issues. Additional focus on Austria, Switzerland and Scandinavia. (2 partners, 7 associates)
Clients: ?? UBS, Berenberg, Zürcher Kantonalbank on IPO of Zur Rose; SGL on rights issue; JPMorgan, UBS on secondary offering of TLG; DNA Oyi on IPO; MorphoSys on private placement.
  • Teilen